THERAPROXEN-500- naproxen, .gamma.-aminobutyric acid kit

Страна: САЩ

Език: английски

Източник: NLM (National Library of Medicine)

Активна съставка:

NAPROXEN (UNII: 57Y76R9ATQ) (NAPROXEN - UNII:57Y76R9ATQ)

Предлага се от:

Physician Therapeutics LLC

INN (Международно Name):

NAPROXEN

Композиция:

NAPROXEN 500 mg

Вид предписание :

PRESCRIPTION DRUG

Терапевтични показания:

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of naproxen, naproxen sodium and other treatment options before deciding to use naproxen and naproxen sodium tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). Naproxen as naproxen or naproxen sodium tablets are indicated: - For the relief of the signs and symptoms of rheumatoid arthritis - For the relief of the signs and symptoms of osteoarthritis - For the relief of the signs and symptoms of ankylosing spondylitis - For the relief of the signs and symptoms of juvenile arthritis Naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient’s weight. Naproxen as naproxen and naproxen sodium tablets are also indicated: - For relief of the signs and symptoms of tendonitis - For relief of the signs and symptoms of bursitis - For relief of the signs and symptoms

Каталог на резюме:

How Supplied   Theramine is supplied in purple and white, size 0 capsules in bottles of 60 or 90 capsules.   Physician Supervision   Theramine is a Medical Food product available by prescription only and must be used while the patient is under ongoing physician supervision.  U.S. patent pending.  Manufactured by Arizona Nutritional Supplements, Inc. Chandler AZ 85225   Distributed by Physician Therapeutics LLC, Los Angeles, CA 90077. www.ptlcentral.com   Copyright 2003-2006, Physician Therapeutics LLC, all rights reserved   NDC: 68405-1008-02   NDC: 68405-1008-03

Статус Оторизация:

unapproved drug other

Листовка

Physician Therapeutics LLC
Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been
approved by FDA. For further information about unapproved drugs, click
here.
----------
MEDICATION GUIDE FOR NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
(See the end of this Medication Guide for a list of prescription NSAID
medicines.)
What is the most important information I should know about medicines
called Non-Steroidal Anti-
Inflammatory Drugs (NSAIDs)?
NSAID medicines may increase the chance of a heart attack or stroke
that can lead to death. This chance
increases:
- with longer use of NSAID medicines
- in people who have heart disease
NSAID medicines should never be used right before or after a heart
surgery called a “coronary artery
bypass graft (CABG).”
NSAID medicines can cause ulcers and bleeding in the stomach and
intestines at any time during
treatment. Ulcers and bleeding:
- can happen without warning symptoms
- may cause death
The chance of a person getting an ulcer or bleeding increases with:
- taking medicines called “corticosteroids” and
“anticoagulants”
- longer use
- smoking
- drinking alcohol
- older age
- having poor health
NSAID medicines should only be used:
- exactly as prescribed
- at the lowest dose possible for your treatment
- for the shortest time needed
What are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?
NSAID medicines are used to treat pain and redness, swelling, and heat
(inflammation) from medical
conditions such as:
- different types of arthritis
- menstrual cramps and other types of short-term pain
Who should not take a Non-Steroidal Anti-Inflammatory Drug (NSAID)?
Do not take an NSAID medicine:
- if you had an asthma attack, hives, or other allergic reaction with
aspirin or any other NSAID medicine
- for pain right before or after heart bypass surgery
Tell your healthcare provider:
- about all your medical conditions.
- about all of the medicines you take. NSAIDs and some other medicines
can interact with each other and
cause

Данни за продукта

THERAPROXEN-500 - NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID
PHYSICIAN THERAPEUTICS LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
THERAPROXEN-500
DESCRIPTION
Naproxen USP is a proprionic acid derivative related to the arylacetic
acid group of nonsteroidal anti-
inflammatory drugs. The chemical names for naproxen USP and naproxen
sodium USP are (S)-6-
methoxy-a-methyl-2-naphthaleneacetic acid and
(S)-6-methoxy-a-methyl-2-naphthaleneacetic acid,
sodium salt, respectively. Naproxen USP and naproxen sodium USP have
the following structures,
respectively:
Naproxen USP has a molecular weight of 230.26 and a molecular formula
of C14H14O3. Naproxen
sodium USP has a molecular weight of 252.23 and a molecular formula of
C14H13NaO3. Naproxen
USP is an odorless, white to off-white crystalline substance. It is
lipid-soluble, practically insoluble in
water at low pH and freely soluble in water at high pH. The
octanol/water partition coefficient of
naproxen USP at pH 7.4 is 1.6 to 1.8. Naproxen sodium USP is a white
to creamy white, crystalline
solid, freely soluble in water at neutral pH. Naproxen tablets USP are
available as light orange colored
tablets containing 250 mg of naproxen USP, light orange colored
tablets containing 375 mg of naproxen
USP and light orange colored tablets containing 500 mg of naproxen USP
for oral administration. The
inactive ingredients are microcrystalline cellulose, croscarmellose
sodium, iron oxides, povidone and
magnesium stearate. Naproxen sodium tablets USP are available as blue
tablets containing 275 mg of
naproxen sodium USP and as blue tablets containing 550 mg of naproxen
sodium USP for oral
administration. The inactive ingredients are croscarmellose sodium,
colloidal silicon dioxide,
povidone, magnesium stearate, microcrystalline cellulose and talc. The
coating suspension for the
naproxen sodium 275 mg tablet may contain Opadry blue 03F50544.